Growing adoption of GLP-1 drugs could boost annual apparel spending to $13 billion as users splurge on new apparel to support shrinking sizes during their weight-loss journeys, according to Bernstein Research. Athletic apparel brands, off-pricers and online personal styling services (e.g., Stitch Fix) are expected to be the big beneficiaries of the trend.